{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:54Z","timestamp":1761129594315,"version":"3.37.3"},"reference-count":22,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development (AMED)","doi-asserted-by":"publisher","award":["JP18fk0108004","JP18fk0108066"],"award-info":[{"award-number":["JP18fk0108004","JP18fk0108066"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.02.034","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T03:28:26Z","timestamp":1551497306000},"page":"1964-1971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan"],"prefix":"10.1016","volume":"37","author":[{"given":"Hiroshi","family":"Satoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Tanaka-Taya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiemi","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terue","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masae","family":"Itamochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyabi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Okamoto-Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeko","family":"Morino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.02.034_b0005","unstructured":"National Institute of Infectious Diseases. Annual report of the NESVPD. Poliomyelitis. Ministry of Health, Labour and Welfare; 1980 [in Japanese]."},{"key":"10.1016\/j.vaccine.2019.02.034_b0010","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1348-0421.1983.tb02939.x","article-title":"Antigenic and biochemical characterization of poliovirus type 1 isolates of non-vaccine origin","volume":"27","author":"Hara","year":"1983","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2019.02.034_b0015","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1016\/j.vaccine.2014.04.023","article-title":"Polio vaccines: WHO position paper, January 2014-recommendations","volume":"32","author":"World Health Organization","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.034_b0020","unstructured":"Ministry of Health, Labour and Welfare. Poliomyelitis and polio vaccine Q&A; 2016 [last accessed 2018.05.17] [in Japanese], <http:\/\/www.mhlw.go.jp\/bunya\/kenkou\/polio\/qa.html>."},{"key":"10.1016\/j.vaccine.2019.02.034_b0025","unstructured":"National Institute of Infectious Diseases. Protocol for the NESVPD. Ministry of Health, Labour and Welfare; 2011 [in Japanese]."},{"key":"10.1016\/j.vaccine.2019.02.034_b0030","unstructured":"National Institute of Infectious Diseases. Procedure for the NESVPD. Poliomyelitis. Ministry of Health, Labour and Welfare; 2002 [in Japanese]."},{"key":"10.1016\/j.vaccine.2019.02.034_b0035","unstructured":"Ministry of Health, Labour and Welfare. A survey of vaccination status in routine immunization; 2014 [last accessed 2018.05.17] [in Japanese], <http:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html>."},{"key":"10.1016\/j.vaccine.2019.02.034_b0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7883\/yoken.63.216","article-title":"A case of paralytic poliomyelitis associated with poliovirus vaccine strains in Hokkaido","volume":"63","author":"Miyoshi","year":"2010","journal-title":"Japan. Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.034_b0045","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s10156-010-0065-5","article-title":"Vaccine-associated paralytic poliomyelitis in an infant with perianal abscesses","volume":"16","author":"Higashigawa","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2019.02.034_b0050","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1442-200X.2010.03132.x","article-title":"Vaccine-associated paralytic poliomyelitis in a non-immunocompromised infant","volume":"52","author":"Asahina","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2019.02.034_b0055","unstructured":"Ministry of Health, Labour and Welfare. The first conference on smooth promotion for IPV introduction; 2011 [last accessed 2018.05.17] [in Japanese], <http:\/\/www.mhlw.go.jp\/stf\/shingi\/2r9852000001nkzz-att\/2r9852000001nl5a.pdf>."},{"key":"10.1016\/j.vaccine.2019.02.034_b0060","unstructured":"Ministry of Health, Labour and Welfare. Polio vaccination coverage by routine OPV immunization in 2012; 2012 [last accessed 2018.05.17] [in Japanese], <http:\/\/www.mhlw.go.jp\/bunya\/kenkou\/polio\/dl\/121102-1.pdf>."},{"key":"10.1016\/j.vaccine.2019.02.034_b0065","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.034_b0070","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1016\/j.vaccine.2016.08.032","article-title":"Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants","volume":"34","author":"Kaliappan","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.034_b0075","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1186\/s12889-016-3386-1","article-title":"Seroprevalence of poliovirus antibodies in the United States population, 2009\u20132010","volume":"16","author":"Wallace","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.02.034_b0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1017\/S0950268803001663","article-title":"A seroprevalence study of poliovirus antibody among primary schoolchildren in Korea","volume":"132","author":"Jee","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2019.02.034_b0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12879-015-0894-z","article-title":"A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.034_b0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jit155","article-title":"Phase II and III clinical studies of diphtheria-tetanus-acellular pertussis vaccine containing inactivated polio vaccine derived from Sabin strains (DTaP-sIPV)","volume":"208","author":"Okada","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.034_b0095","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.vaccine.2014.11.015","article-title":"Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan","volume":"34","author":"Shimizu","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.02.034_b0100","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/cid\/cix110","article-title":"Immune serum from Sabin inactivated poliovirus vaccine immunization neutralizes multiple individual wild and vaccine-derived polioviruses","volume":"64","author":"Sun","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.02.034_b0105","unstructured":"World Health Organization. Polio eradication and endgame strategic plan 2013\u20132018, 2013 [last accessed 2018.05.17], <http:\/\/polioeradication.org\/who-we-are\/strategy>."},{"key":"10.1016\/j.vaccine.2019.02.034_b0110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.biologicals.2016.08.005","article-title":"Development of inactivated poliovirus vaccine from Sabin strains: a progress report","volume":"44","author":"Okayasu","year":"2016","journal-title":"Biologicals"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19302294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T22:42:16Z","timestamp":1663022536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19302294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":22,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19302294"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polio vaccination coverage and seroprevalence of poliovirus antibodies after the introduction of inactivated poliovirus vaccines for routine immunization in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.02.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}